Sökresultat
Studier visar: Livsstilsinterventioner viktiga för att bromsa Alzheimers sjukdom
…r at the FINGERS Brain Health Institute, and ADDF board member, led the six-month MIND-ADmini trial, which found multimodal lifestyle intervention, alone or combined with medical food, was well tolerated among patients with early-stage Alzheimer’s. The study also learned that those who combined lifestyle intervention with medical food reduced their vascular risk and had less cognitive decline than patients who only engaged in lifestyle interventio…
Eli Lillys Kisunla⹠godkÀnd av FDA för behandling av tidig symtomatisk Alzheimers sjukdom
…I am encouraged by the potential to stop treatment, which could reduce out-of-pocket costs and infusion burden for eligible patients,” said Howard Fillit, M.D., Co-Founder and Chief Science Officer at the Alzheimer’s Drug Discovery Foundation (ADDF). ”Diagnosing and treating Alzheimer’s sooner than we do today has the potential to meaningfully slow disease progression, giving patients invaluable time to maintain their independence for longer.” Lä…
Nya data för Spinraza bekrÀftar bibehÄllen effekt och sÀkerhet över tid för ett brett spektrum av patienter med spinal muskel atrofi
…up to six and a half years. Key highlights include: Patients with infantile-onset SMA included in the ENDEAR-SHINE study (n=105) and who had earlier initiation of SPINRAZA treatment experienced the greatest benefit, and those with later initiation showed evidence of motor function stabilization or improvement. A separate analysis evaluated a cohort of seven young adults (Type 2 or 3) who began treatment with SPINRAZA as teenagers (aged 13 to nearl…
AI-röster luras, men hjÀrnans svar skiljer sig Ät
…AI voices, according to research presented today (Tuesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024. The study was presented by doctoral researcher Christine Skjegstad, and carried out by Ms Skjegstad and Professor Sascha Frühholz, both from the Department of Psychology at the University of Oslo (UiO), Norway. Ms Skjegstad said: “We already know that AI-generated voices have become so advanced that they are nearly in…
CancerlÀkemedel kan stoppa spridningen av Parkinsons sjukdom
…” the human immune system what to seek and destroy. Aplp1’s bond with Lag3 on the cell’s surface enables healthy brain cells to absorb traveling clumps of alpha-synuclein, leading to cell death, the researchers say. Credit: Neuroscience News “Now that we know how Aplp1 and Lag3 interact, we have a new way of understanding how alpha-synuclein contributes to the disease progression of Parkinson’s disease,” says Xiaobo Mao, Ph.D., associate professor…